CONMED (NYSE: CNMD) appoints Andrew Moller interim principal financial officer

Rhea-AI Filing Summary

CONMED Corporation reported that Andrew Moller, age 51, will become Interim Principal Financial Officer effective March 15, 2026. He currently serves as Vice President, Corporate Controller and has been the Company’s Principal Accounting Officer since April 2025.

Before joining CONMED in January 2025, Moller held senior finance roles at Smith & Nephew, including Global Controller and CFO Asia-Pacific, and previously worked at Stanley Black & Decker. The company states there are no related-party transactions or family relationships involving Moller and its directors, and his compensation arrangements are unchanged with this interim appointment.

false 0000816956 0000816956 2026-03-13 2026-03-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15 (d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): March 13, 2026

CONMED CORPORATION

(Exact name of registrant as specified in its charter)

Delaware		001-39218		16-0977505
(State or other jurisdiction of incorporation or organization)		(Commission File Number)		(I.R.S. Employer Identification No.)

11311 Concept Blvd Largo, FL		33773
(Address of principal executive offices)		(Zip code)

(727) 392-6464

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (See General Instruction A.2 below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Rule 12(b) of the Act

Title of each class		Trading Symbol		Name of each exchange on which registered
Common Stock, $0.01 par value		CNMD		NYSE

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 13, 2026, CONMED Corporation (the “Company”) announced that Andrew Moller, age 51, will be appointed Interim Principal Financial Officer of the Company effective March 15, 2026.

Mr. Moller joined the Company in January 2025 as Vice President, Corporate Controller and was appointed as the Company’s Principal Accounting Officer in April 2025. Prior to joining the Company, he was employed by Smith & Nephew from May 2019 to December 2024, where he most recently served as Global Controller and CFO Asia-Pacific. Prior to those roles, Mr. Moller served in a variety of roles at Stanley Black & Decker from 2011 to 2019, including Director of Internal Audit. Mr. Moller is a certified public accountant, and he holds a Master of International Business Studies from the University of South Carolina and a Bachelor of Science degree in Business Administration from the College of Charleston.

There are no related-party transactions that would be required to be disclosed under Item 404(a) of Regulation S-K with respect to Mr. Moller. There are no family relationships between Mr. Moller and the members of the Company’s Board of Directors. There was no change to Mr. Moller’s compensation arrangements in connection with his appointment as Interim Principal Financial Officer.

1

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: March 13, 2026	CONMED CORPORATION
	(Registrant)
	By:	/s/ Patrick J. Beyer
	Name:	Patrick J. Beyer
	Title:	President and Chief Executive Officer

2

FAQ

What executive change did CONMED (CNMD) announce on March 13, 2026?

CONMED announced Andrew Moller will serve as Interim Principal Financial Officer effective March 15, 2026. He steps into this interim finance leadership role while continuing his responsibilities that include having served as Principal Accounting Officer since April 2025.

Who is Andrew Moller, CONMED (CNMD)’s new Interim Principal Financial Officer?

Andrew Moller is CONMED’s Vice President, Corporate Controller and Principal Accounting Officer. He joined in January 2025 after senior roles at Smith & Nephew and Stanley Black & Decker and is a certified public accountant with advanced business degrees.

When does Andrew Moller’s interim role at CONMED (CNMD) become effective?

Andrew Moller’s appointment as Interim Principal Financial Officer becomes effective March 15, 2026. The company disclosed the decision on March 13, 2026, providing investors clarity on who is overseeing principal financial officer responsibilities from that date.

Did CONMED (CNMD) change Andrew Moller’s compensation for his interim appointment?

CONMED did not change Andrew Moller’s compensation in connection with his interim appointment. The company specifically notes that his existing compensation arrangements remain the same even as he assumes the Interim Principal Financial Officer role.

Are there related-party or family relationships involving CONMED (CNMD)’s Andrew Moller?

CONMED states there are no related-party transactions requiring disclosure involving Andrew Moller. The company also notes there are no family relationships between him and members of the Board of Directors, addressing potential conflict-of-interest concerns.

What prior experience does CONMED (CNMD)’s Interim Principal Financial Officer have?

Before CONMED, Andrew Moller worked at Smith & Nephew and Stanley Black & Decker. His roles included Global Controller, CFO Asia-Pacific, and Director of Internal Audit, providing extensive international and governance-focused finance experience.

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL SCHEMA FILE 2.9 KB
• EX-101 XBRL LABEL FILE 33.4 KB
• EX-101 XBRL PRESENTATION FILE 21.8 KB